Viewing Study NCT02364635


Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2026-01-25 @ 2:20 AM
Study NCT ID: NCT02364635
Status: COMPLETED
Last Update Posted: 2015-09-29
First Post: 2015-01-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects
Sponsor: Pronova BioPharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module